dihexa approval status fda 1mL(10 mM in DMSO) - Neurotrophic Peptide Enhancer 2025's FDA approvals by regulatory

No human clinical trials of Dihexa itself have been published in peer-reviewed literature as of 2026

Despite the use of rodents and small mammals being commonplace in research, in particular for the development of novel therapeutic agents, caution still needs to be practiced when extrapolating research data to clinical applications

Umbrella Labs positions this specification forward approach as a practical requirement for high rigor bench science where outcomes must be compared across repeated experiments

Z.VuleticL

In the SURMOUNT-1 obesity trial, tirzepatide produced mean weight reductions of roughly 1521% depending on dose over 72 weeks ( Jastreboff et al., NEJM 2022